Sandy Spring Bank
HELP icon

Sandy Spring Bank’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Sandy Spring Bank’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-26
Closed -$229 – 1240
2024
Q4 		$229 Hold
26
– – ﹤0.01% 1165
2024
Q3 		$231 Hold
26
– – ﹤0.01% 1149
2024
Q2 		$271 Hold
26
– – ﹤0.01% 1208
2024
Q1 		$414 Hold
26
– – ﹤0.01% 1163
2023
Q4 		$410 Hold
26
– – ﹤0.01% 1120
2023
Q3 		$531 Hold
26
– – ﹤0.01% 1119
2023
Q2 		$378 Hold
26
– – ﹤0.01% 1166
2023
Q1 		$385 Hold
26
– – ﹤0.01% 1109
2022
Q4 		$297 Buy
+26
New +$429 ﹤0.01% 1099

Other funds holding HELP

Tang Capital Management
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Rosalind Advisors
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Sphera Funds Management
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Ikarian Capital
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $444M AUM 151.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sandy Spring Bank's HELP Position: Q1 2025 in Review

Sandy Spring Bank sold out of Helus Pharma Inc. Common Stock (HELP) in Q1 2025, closing a stake of 26 shares — an estimated $229 sold.

Sandy Spring Bank first reported a position in HELP in Q4 2022 and held it in 9 quarters. The position peaked at $531 in Q3 2023. 56 funds tracked by Wall St. Rank hold HELP as of Q1 2025.

  • Sandy Spring Bank reported no remaining Helus Pharma Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Sandy Spring Bank sold 26 Helus Pharma Inc. Common Stock shares in Q1 2025, an estimated $229.
  • Sandy Spring Bank first reported a position in Helus Pharma Inc. Common Stock in Q4 2022 and held it in 9 quarters.
  • Sandy Spring Bank's Helus Pharma Inc. Common Stock position peaked at $531 in Q3 2023.
  • 56 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.